Heart, Vascular & Thoracic Institute (Miller Family) Outcomes

The American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR) has several key performance measures to evaluate hospitals. One of these measures is the use of appropriate adjunctive medications after percutaneous coronary intervention (PCI) procedures. In 2023, Cleveland Clinic's Main Campus achieved usage rates near or within the ACC-NCDR's 90th percentile.

Many patients who have percutaneous coronary intervention (PCI) procedures at Cleveland Clinic have complex medical backgrounds, which increase the risk of complications. In addition, Cleveland Clinic interventionalists perform hybrid procedures, which increase the risk of bleeding as defined by The National Cardiovascular Data Registry (NCDR). These hybrid procedures are performed less often at comparable hospitals. Cleveland Clinic is continuously striving to achieve the best possible outcomes for patients while providing the most advanced treatments possible.

Cleveland Clinic performs better than the NCDR 50th percentile.

Risk-adjusted mortality for all patients undergoing PCI at Cleveland Clinic is better than the 90th percentile benchmark.

When emergency ST-elevation myocardial infarction (STEMI) cases are removed from the PCI population, risk-adjusted mortality for patients without a STEMI undergoing PCI at Cleveland Clinic's Main Campus is better than the 90th percentile benchmark.

Cleveland Clinic discharged 59% of elective PCI cases on the same day as the procedure in 2023.

The American College of Cardiology (ACC) guideline for treatment of the lesion causing an ST-elevated myocardial infarction is within 90 minutes of arrival to the facility.

In 2023, Cleveland Clinic performed PCI with a radial approach in 71% of cases, which was more than the national radial artery use at 59%.